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Supplemental figures 
Supplementary Figure 1 A, Comparison of all known synuclein sequences. B, Comparison 
of human, mouse and α-, β- and γ-synuclein sequences. Program used: ClustalW2 
(http://www.ebi.ac.uk/Tools/clustalw2/index.html). 
Supplemental Figure 2: Mapping the CK1 phosphorylation sites: WT, S129A and S129E 
were phosphorylated for 24 h with CK1 and the different phosphorylated species (I,II,III) 
were separated by semi-preparative RP-HPLC and analyzed by MALDI-MS. A, The 
Coomassie blue stained SDS gels of the mono-, di-, and unphosphorylated species of each 
protein. The S129A α-syn was subjected to further trypsin digestion and tandem mass 
spectrometry. B, 4280-4380 m/z inset covering the pseudomolecular region of C-terminal 
peptide [103-140] of S129A analyzed by MALDI-MS in positive ion mode. The peak 
corresponding to the monophosphorylated peptide at m/z 4363.4 could not be detected. C, 
MALDI-MS spectra in negative ion mode showing the m/z region 1450–1850 of the tryptic 
digest of unphosphorylated (blue), monophosphorylated (red), and diphosphorylated (green) 
peaks obtained from an in vitro phosphorylation of S129A with CK1. The peak at m/z 1478.0 
corresponds to the sequence TVEGAGSIAAATGFVKK ([81-96]), which contains three 
potential phosphorylation sites. The difference in mass of 80 or 160 Da is consistent with the 
addition of one and two phosphate groups, respectively. D, CID spectrum of the doubly 
modified peptide [81-96]. Fragmentation pattern of the [M + 2H]2+ 81-96 peptide bearing 
two phosphates on S87 and T92 residues. (Top right) Sequence coverage based on detected y 
and b fragment ions. Ions carrying the phosphate group are shown with one or two stars (* 
and **) on the sequence. 
 
Supplemental Figure 3. CK1-mediated phosphorylation inhibits the fibrillization of S129A 
and S129E α-syn. A, ThT fluorescence measurements of CK1-phosphorylated S129A and B, 
S129E α-syn (100 μM) (white) and their unphosphorylated control (black). S129A and S129E 
α-syn were phosphorylated for 24 h with CK1 and then aggregated for the indicated length of 
time. Negatively stained TEM images of phosphorylated S129A and S129E and their 
unphosphorylated control after 12 h of incubation at 37°C under agitating conditions (scales 
bar 0.2 μm). C, ThT fluorescence measurements of CK1-phosphorylated S129E α-syn (20 
μM). S129E was phosphorylated for 24 h with CK1 and then the different phosphorylated 
species were separated by RP-HPLC. S129E and S129E/S87-P samples were aggregated for 
the indicated length of time. Negatively stained TEM images of S129E and S129E/S87-P 
after 24 h of incubation at 37°C under agitating conditions (scales bar 0.2 μm). 
 
Supplemental Figure 4. A, Comparison of two-dimensional 1H -15N HSQC spectra of 
unphosphorylated WT (blue) and phosphorylated WT (red) α-syn. A dashed rectangle marks 
glutamine and asparagine side chain resonances. B, Comparison of 3J(HN,Hα) scalar 
couplings observed in nonphosphorylated WT (black), nonphosphorylated S129D (blue) and 
phosphorylated S129D (grey) α-syn at 15 °C. C, Comparison of 15N R1ρ spin relaxation rates 
in nonphosphorylated WT (black) and phosphorylated S129D (grey). The domain 
organization of α-syn is shown on the top: basic N-terminal domain (red), hydrophobic NAC 
region (yellow), acidic C-terminal domain (blue) and the six repeats (green). 
Supplemental Figure 5.  In vitro phosphorylation of α-syn monomers and fibrils as a 
function of time by CK1. Samples were separated on a 12% SDS gel and probed with anti-α-
syn (211, 1:500), anti-S129-P (1:5000) or anti-S87-P (1:100) α-syn antibodies.  
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